JDVWX
Price
$29.35
Change
+$0.23 (+0.79%)
Updated
Jul 31 closing price
Net Assets
19.51B
RMEBX
Price
$64.44
Change
+$0.03 (+0.05%)
Updated
Jul 31 closing price
Net Assets
118.05B
Interact to see
Advertisement

JDVWX vs RMEBX

JDVWX vs RMEBX Comparison Chart in %
View a ticker or compare two or three
VS
JDVWX vs. RMEBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVWX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 118B vs. JDVWX (19.5B). RMEBX pays higher dividends than JDVWX: RMEBX (0.99) vs JDVWX (0.77). JDVWX was incepted earlier than RMEBX: JDVWX (15 years) vs RMEBX (12 years). RMEBX (1.07) is less costly to investors than JDVWX (0.61). JDVWX is a more actively managed with annual turnover of: 42.00 vs. RMEBX (30.00). RMEBX has a lower initial minimum investment than JDVWX: RMEBX (250) vs JDVWX (1000000). JDVWX annual gain was more profitable for investors over the last year : 21.93 vs. RMEBX (8.96). RMEBX return over 5 years is better than : 36.13 vs. JDVWX (21.28).
JDVWXRMEBXJDVWX / RMEBX
Total Expense Ratio0.601.0756%
Annual Report Gross Expense Ratio0.611.0757%
Fund Existence15 years12 years-
Gain YTD18.3479.416195%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B118B17%
Annual Yield % from dividends0.770.9978%
Returns for 1 year21.938.96245%
Returns for 3 years33.0832.63101%
Returns for 5 years21.2836.1359%
Returns for 10 years79.0690.6487%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IEOTX15.100.17
+1.14%
Voya Large Cap Growth Port S2
JRAAX88.86N/A
N/A
Janus Henderson Research A
VLLIX45.39-0.03
-0.07%
Value Line Larger Companies Focus Instl
BHCFX21.68-0.10
-0.46%
Baron Health Care Retail
FBDIX193.96-3.99
-2.02%
Franklin Biotechnology Discovery A